[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2987265B1 - Composition pharmaceutique sous forme de sirop a base de modafinil, son procede de fabrication et son application - Google Patents

Composition pharmaceutique sous forme de sirop a base de modafinil, son procede de fabrication et son application

Info

Publication number
FR2987265B1
FR2987265B1 FR1200579A FR1200579A FR2987265B1 FR 2987265 B1 FR2987265 B1 FR 2987265B1 FR 1200579 A FR1200579 A FR 1200579A FR 1200579 A FR1200579 A FR 1200579A FR 2987265 B1 FR2987265 B1 FR 2987265B1
Authority
FR
France
Prior art keywords
modafinil
producing
application
pharmaceutical composition
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1200579A
Other languages
English (en)
Other versions
FR2987265A1 (fr
Inventor
Christophe Lebon
Pascal Suplie
Julie Domergue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Debregeas Et Associes Pharma SAS
Original Assignee
Debregeas Et Associes Pharma SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debregeas Et Associes Pharma SAS filed Critical Debregeas Et Associes Pharma SAS
Priority to FR1200579A priority Critical patent/FR2987265B1/fr
Priority to PCT/FR2013/000050 priority patent/WO2013128086A1/fr
Priority to TW102106510A priority patent/TW201340994A/zh
Priority to ARP130100594A priority patent/AR090167A1/es
Publication of FR2987265A1 publication Critical patent/FR2987265A1/fr
Application granted granted Critical
Publication of FR2987265B1 publication Critical patent/FR2987265B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR1200579A 2012-02-28 2012-02-28 Composition pharmaceutique sous forme de sirop a base de modafinil, son procede de fabrication et son application Expired - Fee Related FR2987265B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR1200579A FR2987265B1 (fr) 2012-02-28 2012-02-28 Composition pharmaceutique sous forme de sirop a base de modafinil, son procede de fabrication et son application
PCT/FR2013/000050 WO2013128086A1 (fr) 2012-02-28 2013-02-25 Composition pharmaceutique sous forme de sirop à base de modafinil, son procédé de fabrication et son application
TW102106510A TW201340994A (zh) 2012-02-28 2013-02-25 呈現莫達非尼糖漿之藥物組成物、其製造方法及其應用
ARP130100594A AR090167A1 (es) 2012-02-28 2013-02-27 Composicion farmaceutica cuyo principio activo es el modafinilo en su forma de enantiomero s presentandose como un jarabe

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1200579A FR2987265B1 (fr) 2012-02-28 2012-02-28 Composition pharmaceutique sous forme de sirop a base de modafinil, son procede de fabrication et son application

Publications (2)

Publication Number Publication Date
FR2987265A1 FR2987265A1 (fr) 2013-08-30
FR2987265B1 true FR2987265B1 (fr) 2014-02-28

Family

ID=48083445

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1200579A Expired - Fee Related FR2987265B1 (fr) 2012-02-28 2012-02-28 Composition pharmaceutique sous forme de sirop a base de modafinil, son procede de fabrication et son application

Country Status (4)

Country Link
AR (1) AR090167A1 (fr)
FR (1) FR2987265B1 (fr)
TW (1) TW201340994A (fr)
WO (1) WO2013128086A1 (fr)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
KR100911952B1 (ko) * 2000-10-11 2009-08-13 세파론, 인코포레이티드 모다피닐 화합물을 포함하는 조성물
US6919378B2 (en) 2000-10-11 2005-07-19 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
US6489363B2 (en) 2000-10-11 2002-12-03 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
US7576133B2 (en) 2002-03-11 2009-08-18 Carl Henry Lawyer Methods and compositions for nasal administration of modafinil
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
US20050008704A1 (en) 2003-07-11 2005-01-13 Ray Anup Kumar Pharmaceutical composition for solubility enhancement of hydrophobic drugs
US20060024370A1 (en) * 2004-07-29 2006-02-02 Cephalon France Modafinil oral lyophilizate
EP1891938A1 (fr) * 2006-07-24 2008-02-27 Cephalon France Haute dose soluble oralement d'une forme de dosage lyophilisé.
US8173169B2 (en) * 2007-07-11 2012-05-08 Hikma Pharmaceuticals Formulation and process for the preparation of modafinil

Also Published As

Publication number Publication date
WO2013128086A1 (fr) 2013-09-06
TW201340994A (zh) 2013-10-16
FR2987265A1 (fr) 2013-08-30
AR090167A1 (es) 2014-10-22

Similar Documents

Publication Publication Date Title
BR112013030472A2 (pt) formulação farmacêutica, artigo de fabricação e método
BR112013033811A2 (pt) composição, método de preparação da composição, e, composto
BR112013031916A2 (pt) composição nucicional,uso de uma composição nutricional, processo para a fabricação de uma composição nutricional, e produto
BR112014010391A2 (pt) composto, composição farmacêutica, processo de produção de uma composição farmacêutica, método de tratamento, kit e uso de uma composição farmacêutica
FR2991320B1 (fr) Procede de preparation d'amines methylees
BR112014010460A2 (pt) composto, composição farmacêutica, processo para produzir uma composição farmacêutica, método de tratamento, kit e uso de uma composição farmacêutica
BR112013007276A2 (pt) composição farmacêutica, processo para preparar uma composição farmacêutica, uso da coposição farmacêutica e método para tratar sobrecarga crônica de ferro
SG11201408156PA (en) Mold base material, production method for mold base material, mold production method, and mold
BR112012026843A2 (pt) composição, composição farmacêutica, processo para preparar uma composição farmacêutica, uso de uma composição e método para tratamento de hiv
BR112014020603A2 (pt) composição formadora de gel, unidade de envidraçamento, processo para formar uma unidade de envidraçamento, e, método para fabricar uma composição formadora de gel
PL2770827T3 (pl) Kompozycja, sposób otrzymywania kompozycji i zawierająca ją formulacja fitosanitarna
EP2851421A4 (fr) Microorganisme utile, et procédé de production d'une substance souhaitée
CO6862129A2 (es) Aparato y proceso para la producción de un producto de células encapsuladas
BR112012021066A2 (pt) processo de preparação de uma composição, composição e aplicação da composição
BR112014026565A2 (pt) formulação, uso de uma formulação, e, processo para produzir uma formulação
BR112015026371A2 (pt) composição para a preparação de bactéria probiótica, produto alimentar líquido, processo para a preparação de bactéria probiótica, e processo para a preparação de um produto alimentar com base líquida
FR2985734B1 (fr) Composition de biocombustible et procede de fabrication d'un biocombustible
BR112013022930A2 (pt) composição farmacêutica, uso de uma composição farmacêutica, e, processo para produzir uma composição farmacêutica
BR112014025972A2 (pt) monocloridrato de anamorelina, composição, processo para preparar monocloridrato de anamorelina, composição farmacêutica e método para produzir uma forma de dosagem farmacêutica
BR112012025490A2 (pt) ''método para produção de 1,5 oebtanodiamina''
EP2742946A4 (fr) Procédé pour la production de dérivés de pyrostegia venusta, dérivés de pyrostegia venusta, compositions pharmaceutiques et leurs utilisations
BR112013015501A2 (pt) composto, composição farmacêutica, métodos para tratamento de infecções virais e de distúrbios inflamatórios, e, processo para produzir uma sangliferrina mutassintética
FR2994634B1 (fr) Composition alimentaire a base de spiruline fraiche et procede de preparation
BR112013013415A2 (pt) composição farmacêutica, e, método para a preparação de uma composição
BR112014011745A2 (pt) composição farmacêutica, e, processo para a fabricação de uma composição farmacêutica de hidrocortisona

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

ST Notification of lapse

Effective date: 20201005